ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF
European Patent
20834060.4
Filed on 2020-12-08
20834060.4
Filed on 2020-12-08
ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF
Canada
3161573
Filed on 2020-12-08
3161573
Filed on 2020-12-08
ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF
Australia
2020402752
Filed on 2020-12-08
2020402752
Filed on 2020-12-08
COMPOUNDS FOR TREATING CANCER
France
18745789.0
Filed on 2020-01-03
18745789.0
Filed on 2020-01-03
COMPOUNDS FOR TREATING CANCER
Spain
18745789.0
Filed on 2020-01-03
18745789.0
Filed on 2020-01-03
COMPOUNDS FOR TREATING CANCER
Germany
18745789.0
Filed on 2020-01-03
18745789.0
Filed on 2020-01-03
COMPOUNDS FOR TREATING CANCER
United Kingdom
18745789.0
Filed on 2020-01-03
18745789.0
Filed on 2020-01-03
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
US Patent 12,029,794
Filed on 2021-12-02
Filed on 2021-12-02
Combing D2C7 Immunotoxin With Check Points Inhibitors
United Kingdom
16863025.9
Filed on 2016-11-04
16863025.9
Filed on 2016-11-04
Combing D2C7 Immunotoxin With Check Points Inhibitors
France
16863025.9
Filed on 2016-11-04
16863025.9
Filed on 2016-11-04